Difference between revisions of "Template:Histamine receptor modulators"
Jump to navigation
Jump to search
imported>Bait30 (remove unnecessary commas) |
|||
| (57 intermediate revisions by 19 users not shown) | |||
| Line 1: | Line 1: | ||
{{Navbox | {{Navbox | ||
| − | | name | + | | name = Histamine receptor modulators |
| − | | title = [[ | + | | title = [[Histamine receptor]] [[receptor modulator|modulator]]s |
| − | | state = {{{state| | + | | state = {{{state<includeonly>|collapsed</includeonly>}}} |
| + | | border = {{{border|}}} | ||
| listclass = hlist | | listclass = hlist | ||
| − | | groupstyle = | + | | groupstyle = text-align: center; |
| − | + | | group1 = [[Histamine H1 receptor|H<sub>1</sub>]] | |
| − | + | | list1 = | |
| − | + | * '''Agonists:''' [[2-Pyridylethylamine]] | |
| − | |||
| − | |||
| − | |||
| − | * '''Agonists''' | ||
* [[Betahistine]] | * [[Betahistine]] | ||
* [[Histamine]] | * [[Histamine]] | ||
* [[Histamine trifluoromethyl toluidide|HTMT]] | * [[Histamine trifluoromethyl toluidide|HTMT]] | ||
| − | * [[UR-AK49]] | + | * [[L-Histidine|{{smaller|L}}-Histidine]]<!--Precursor--> |
| + | * [[UR-AK49]] | ||
| + | |||
| + | * '''Antagonists:''' ''First-generation:'' [[4-Methyldiphenhydramine]] | ||
* [[Alimemazine]] | * [[Alimemazine]] | ||
* [[Antazoline]] | * [[Antazoline]] | ||
* [[Azatadine]] | * [[Azatadine]] | ||
* [[Bamipine]] | * [[Bamipine]] | ||
| − | * [[Benzatropine|Benzatropine | + | * [[Benzatropine|Benzatropine (benztropine)]] |
* [[Bepotastine]] | * [[Bepotastine]] | ||
* [[Bromazine]] | * [[Bromazine]] | ||
| Line 37: | Line 37: | ||
* [[Clobenzepam]] | * [[Clobenzepam]] | ||
* [[Clocinizine]] | * [[Clocinizine]] | ||
| + | * [[Cloperastine]] | ||
* [[Cyclizine]] | * [[Cyclizine]] | ||
* [[Cyproheptadine]] | * [[Cyproheptadine]] | ||
* [[Dacemazine]] | * [[Dacemazine]] | ||
| + | * [[Decloxizine]] | ||
* [[Deptropine]] | * [[Deptropine]] | ||
* [[Dexbrompheniramine]] | * [[Dexbrompheniramine]] | ||
| Line 50: | Line 52: | ||
* [[Embramine]] | * [[Embramine]] | ||
* [[Etodroxizine]] | * [[Etodroxizine]] | ||
| − | * [[Etybenzatropine|Etybenzatropine | + | * [[Etybenzatropine|Etybenzatropine (ethylbenztropine)]] |
* [[Etymemazine]] | * [[Etymemazine]] | ||
| + | * [[Fenethazine]] | ||
* [[Flunarizine]] | * [[Flunarizine]] | ||
* [[Histapyrrodine]] | * [[Histapyrrodine]] | ||
| Line 60: | Line 63: | ||
* [[Isothipendyl]] | * [[Isothipendyl]] | ||
* [[Meclozine]] | * [[Meclozine]] | ||
| − | * [[Mepyramine|Mepyramine | + | * [[Medrylamine]] |
| + | * [[Mepyramine|Mepyramine (pyrilamine)]] | ||
* [[Mequitazine]] | * [[Mequitazine]] | ||
* [[Methafurylene]] | * [[Methafurylene]] | ||
| Line 66: | Line 70: | ||
* [[Methdilazine]] | * [[Methdilazine]] | ||
* [[Moxastine]] | * [[Moxastine]] | ||
| − | |||
* [[Orphenadrine]] | * [[Orphenadrine]] | ||
* [[Oxatomide]] | * [[Oxatomide]] | ||
* [[Oxomemazine]] | * [[Oxomemazine]] | ||
| + | * [[Perlapine]] | ||
* [[Phenindamine]] | * [[Phenindamine]] | ||
* [[Pheniramine]] | * [[Pheniramine]] | ||
| Line 88: | Line 92: | ||
* [[Triprolidine]] | * [[Triprolidine]] | ||
| − | * '' | + | * ''Second/third-generation:'' [[Acrivastine]] |
* [[Alinastine]] | * [[Alinastine]] | ||
* [[Astemizole]] | * [[Astemizole]] | ||
| Line 103: | Line 107: | ||
* [[Clemizole]] | * [[Clemizole]] | ||
* [[Clobenztropine]] | * [[Clobenztropine]] | ||
| + | * [[Desloratadine]] | ||
* [[Dorastine]] | * [[Dorastine]] | ||
* [[Ebastine]] | * [[Ebastine]] | ||
| + | * [[Efletirizine]] | ||
* [[Emedastine]] | * [[Emedastine]] | ||
* [[Epinastine]] | * [[Epinastine]] | ||
| + | * [[Fexofenadine]] | ||
* [[Flezelastine]] | * [[Flezelastine]] | ||
* [[Ketotifen]] | * [[Ketotifen]] | ||
* [[Latrepirdine]] | * [[Latrepirdine]] | ||
* [[Levocabastine]] | * [[Levocabastine]] | ||
| + | * [[Levocetirizine]] | ||
* [[Linetastine]] | * [[Linetastine]] | ||
* [[Loratadine]] | * [[Loratadine]] | ||
| Line 121: | Line 129: | ||
* [[Olopatadine]] | * [[Olopatadine]] | ||
* [[Perastine]] | * [[Perastine]] | ||
| + | * [[Pibaxizine]] | ||
* [[Piclopastine]] | * [[Piclopastine]] | ||
| + | * [[Quifenadine|Quifenadine (phencarol)]] | ||
* [[Rocastine]] | * [[Rocastine]] | ||
* [[Rupatadine]] | * [[Rupatadine]] | ||
* [[Setastine]] | * [[Setastine]] | ||
| + | * [[Sequifenadine|Sequifenadine (bicarphen)]] | ||
* [[Talastine]] | * [[Talastine]] | ||
* [[Temelastine]] | * [[Temelastine]] | ||
* [[Terfenadine]] | * [[Terfenadine]] | ||
| + | * [[Vapitadine]] | ||
* [[Zepastine]] | * [[Zepastine]] | ||
| − | * '' | + | * ''Others:'' [[Atypical antipsychotic]]s (e.g., [[aripiprazole]], [[asenapine]], [[brexpiprazole]], [[brilaroxazine]], [[clozapine]], [[iloperidone]], [[olanzapine]], [[paliperidone]], [[quetiapine]], [[risperidone]], [[ziprasidone]], [[zotepine]]) |
| − | * [[ | + | * [[Phenylpiperazine]] [[antidepressant]]s (e.g., [[hydroxynefazodone]], [[nefazodone]], [[trazodone]], [[triazoledione]]) |
| − | * [[ | + | * [[Tetracyclic antidepressant]]s (e.g., [[amoxapine]], [[loxapine]], [[maprotiline]], [[mianserin]], [[mirtazapine]], [[oxaprotiline]]) |
| + | * [[Tricyclic antidepressant]]s (e.g., [[amitriptyline]], [[butriptyline]], [[clomipramine]], [[desipramine]], [[Dosulepin|dosulepin (dothiepin)]], [[doxepin]], [[imipramine]], [[iprindole]], [[lofepramine]], [[nortriptyline]], [[protriptyline]], [[trimipramine]]) | ||
| + | * [[Typical antipsychotic]]s (e.g., [[chlorpromazine]], [[flupenthixol]], [[fluphenazine]], [[loxapine]], [[perphenazine]], [[prochlorperazine]], [[thioridazine]], [[thiothixene]]) | ||
| − | * '' | + | * ''Unknown/unsorted:'' [[Azanator]] |
| − | * [[ | + | * [[Belarizine]] |
* [[Elbanizine]] | * [[Elbanizine]] | ||
* [[Flotrenizine]] | * [[Flotrenizine]] | ||
| − | * [[ | + | * [[GSK1004723]] |
* [[Napactadine]] | * [[Napactadine]] | ||
| − | |||
* [[Tagorizine]] | * [[Tagorizine]] | ||
* [[Trelnarizine]] | * [[Trelnarizine]] | ||
* [[Trenizine]] | * [[Trenizine]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | + | | group2 = [[Histamine H2 receptor|H<sub>2</sub>]] | |
| − | + | | list2 = | |
| − | * '''Agonists''' | + | * '''Agonists:''' [[Amthamine]] |
* [[Betazole]] | * [[Betazole]] | ||
* [[Dimaprit]] | * [[Dimaprit]] | ||
| Line 165: | Line 166: | ||
* [[Histamine trifluoromethyl toluidide|HTMT]] | * [[Histamine trifluoromethyl toluidide|HTMT]] | ||
* [[Impromidine]] | * [[Impromidine]] | ||
| − | * [[UR-AK49]] | + | * [[L-Histidine|{{smaller|L}}-Histidine]]<!--Precursor--> |
| + | * [[UR-AK49]] | ||
| + | |||
| + | * '''Antagonists:''' [[Bisfentidine]] | ||
* [[Burimamide]] | * [[Burimamide]] | ||
* [[Cimetidine]] | * [[Cimetidine]] | ||
| Line 173: | Line 177: | ||
* [[Etintidine]] | * [[Etintidine]] | ||
* [[Famotidine]] | * [[Famotidine]] | ||
| + | * [[Isolamtidine]] | ||
* [[Lafutidine]] | * [[Lafutidine]] | ||
* [[Lamtidine]] | * [[Lamtidine]] | ||
| − | * [[Lavoltidine|Lavoltidine | + | * [[Lavoltidine|Lavoltidine (loxtidine)]] |
* [[Lupitidine]] | * [[Lupitidine]] | ||
* [[Metiamide]] | * [[Metiamide]] | ||
| Line 184: | Line 189: | ||
* [[Oxmetidine]] | * [[Oxmetidine]] | ||
* [[Pibutidine]] | * [[Pibutidine]] | ||
| − | * [[Quisultazine|Quisultazine | + | * [[Quisultazine|Quisultazine (quisultidine)]] |
* [[Ramixotidine]] | * [[Ramixotidine]] | ||
* [[Ranitidine]] | * [[Ranitidine]] | ||
| Line 193: | Line 198: | ||
* [[Venritidine]] | * [[Venritidine]] | ||
* [[Xaltidine]] | * [[Xaltidine]] | ||
| + | * [[Zolantidine]] | ||
| − | + | | group3 = [[Histamine H3 receptor|H<sub>3</sub>]] | |
| − | + | | list3 = | |
| − | * '''Agonists''' | + | * '''Agonists:''' [[alpha-Methylhistamine|α-Methylhistamine]] |
* [[Cipralisant]] | * [[Cipralisant]] | ||
* [[Histamine]] | * [[Histamine]] | ||
| Line 202: | Line 208: | ||
* [[Immepip]] | * [[Immepip]] | ||
* [[Immethridine]] | * [[Immethridine]] | ||
| + | * [[L-Histidine|{{smaller|L}}-Histidine]]<!--Precursor--> | ||
* [[Methimepip]] | * [[Methimepip]] | ||
| − | * [[Proxyfan]] | + | * [[Proxyfan]] |
| − | * [[A- | + | |
| + | * '''Antagonists:''' [[A-349821]] | ||
| + | * [[A-423579]] | ||
* [[ABT-239]] | * [[ABT-239]] | ||
| + | * [[ABT-652]] | ||
| + | * [[AZD5213]] | ||
| + | * [[Bavisant]] | ||
* [[Betahistine]] | * [[Betahistine]] | ||
* [[Burimamide]] | * [[Burimamide]] | ||
| Line 211: | Line 223: | ||
* [[Clobenpropit]] | * [[Clobenpropit]] | ||
* [[Conessine]] | * [[Conessine]] | ||
| − | * [[GSK- | + | * [[Enerisant]] |
| + | * [[GSK-189254]] | ||
* [[Impentamine]] | * [[Impentamine]] | ||
* [[Iodophenpropit]] | * [[Iodophenpropit]] | ||
| − | * [[ | + | * [[Irdabisant]] |
| − | * [[ | + | * [[JNJ-5207852]] |
| − | * [[NNC 38-1049 | + | * [[NNC 38-1049]] |
* [[PF-03654746]] | * [[PF-03654746]] | ||
* [[Pitolisant]] | * [[Pitolisant]] | ||
| − | * [[SCH-79687 | + | * [[SCH-79687]] |
* [[Thioperamide]] | * [[Thioperamide]] | ||
| − | * [[VUF-5681 | + | * [[VUF-5681]] |
| − | + | | group4 = [[Histamine H4 receptor|H<sub>4</sub>]] | |
| − | + | | list4 = | |
| − | * '''Agonists''' | + | * '''Agonists:''' [[4-Methylhistamine]] |
* [[alpha-Methylhistamine|α-Methylhistamine]] | * [[alpha-Methylhistamine|α-Methylhistamine]] | ||
* [[Histamine]] | * [[Histamine]] | ||
| − | * [[ | + | * [[L-Histidine|{{smaller|L}}-Histidine]]<!--Precursor--> |
| + | * [[OUP-16]] | ||
| + | * [[VUF-8430]] | ||
| + | |||
| + | * '''Antagonists:''' [[JNJ-7777120]] | ||
| + | * [[Mianserin]] | ||
| + | * [[Seliforant]] | ||
* [[Thioperamide]] | * [[Thioperamide]] | ||
| − | * [[ | + | * [[Toreforant]] |
| − | + | * [[VUF-6002]] | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | * | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | + | | below = '''''See also:''' [[Template:Receptor modulators|Receptor/signaling modulators]] • [[Template:Monoamine metabolism modulators|Monoamine metabolism modulators]] • [[Template:Monoamine reuptake inhibitors|Monoamine reuptake inhibitors]]'' | |
| − | }}<noinclude> | + | }} |
| + | <noinclude> | ||
{{collapsible option}} | {{collapsible option}} | ||
[[Category:Drug templates by receptor, channel, or pump]] | [[Category:Drug templates by receptor, channel, or pump]] | ||
</noinclude> | </noinclude> | ||
Latest revision as of 20:13, 11 June 2020
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Histamine receptor modulators|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Histamine receptor modulators|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Histamine receptor modulators|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.